Kevin Bainey

Jun 21, 2024 | medrxiv.org | Alexandra Saunders |Kevin Bainey |Rhea Varughese |Evangelos Michelakis

The authors have declared no competing interest. None receivedI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study received appropriate approvals from the University of Alberta Ethics Board.

Dec 5, 2023 | cjcopen.ca | Byrne R.A |Laurie-Anne Boivin-Proulx |Kevin Bainey |Guillaume Marquis-Gravel

AbstractBalancing the effects of dual antiplatelet therapy (DAPT) in the era of potent purinergic receptor type Y, subtype 12 (P2Y12) inhibitors remains a challenge in the management of acute coronary syndrome (ACS). We conducted a systematic review and meta-analysis following a 2-stage process consisting of searching for systematic reviews published between 2019 and November 2022.

Oct 28, 2023 | onlinecjc.ca | Kevin Bainey |Guillaume Marquis-Gravel |Emilie P Belley-Cote |Ricky Turgeon

•Current practice emphasizes consideration for maintenance of chronic ASA therapy before elective coronary angiography. For elective coronary angiography with possibility of PCI, if a patient is not on chronic ASA therapy, a loading dose of ASA is usually administered orally before the procedure. •For planned elective PCI, current practice emphasizes consideration for pre-treatment with DAPT at least 2 hours before PCI.

Oct 28, 2023 | onlinecjc.ca | Kevin Bainey |Guillaume Marquis-Gravel |Emilie P Belley-Cote |Ricky Turgeon

AbstractAntiplatelet therapy (APT) is the foundation of treatment and prevention of atherothrombotic events in patients with atherosclerotic cardiovascular disease. Selecting the optimal APT strategies to reduce major adverse cardiovascular events, while balancing bleeding risk, requires ongoing review of clinical trials.

Sep 1, 2023 | journals.plos.org | Kevin Bainey |Guillaume Marquis-Gravel |Blair MacDonald

Loading metrics Open Access Peer-reviewedResearch Article Citation: Bainey KR, Marquis-Gravel G, MacDonald BJ, Bewick D, Yan A, Turgeon RD (2023) Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis. PLoS ONE 18(9): e0291061. https://doi.org/10.1371/journal.pone.0291061Editor: R.